The Countries Where Americans Are Flying for Cancer Treatment That Costs a Fraction of What It Does at Home
Cancer treatment costs in the U.S. remain a major financial strain, with KFF reporting in recent years that cancer care can leave patients facing large out-of-pocket bills even when they have insurance. That price pressure is helping drive a small but visible stream of Americans to Mexico, India and Turkey for lower-cost oncology care offered through private hospitals and medical tourism agencies.
Mexico, India and Turkey are the countries most often marketed to U.S. patients
Mexico is the closest option for many Americans, especially patients in Texas, Arizona and California who can reach border cities by car or short flight. Private hospitals in Tijuana, Monterrey and Mexico City have advertised oncology consultations, chemotherapy and surgery packages to foreign patients, and medical travel facilitators routinely cite lower prices than U.S. hospitals.
India is also a frequent destination because major private hospital groups in cities including Chennai, Mumbai and New Delhi have long served international patients. Hospitals such as Apollo, Fortis and Max Healthcare have publicly promoted oncology programs for overseas patients, with package pricing that can cover surgery, hospital stays and diagnostics in one quote.
Turkey rounds out the list, largely through private hospitals in Istanbul and Ankara that market cancer surgery, radiation therapy and second opinions to international visitors. Medical tourism platforms and hospital marketing materials have consistently presented Turkey as a lower-cost option than the U.S., although exact prices vary by cancer type, stage and physician plan.
What is known about the cost gap, and what is not
The best-documented part of this trend is the price difference, not the number of Americans making the trip. A 2024 analysis from Patients Beyond Borders and pricing published by international hospitals show that chemotherapy sessions, imaging and some cancer surgeries can run tens of thousands of dollars less abroad than at U.S. hospitals, depending on the treatment plan.
Mexico is often presented as the lower-cost option for consultations, diagnostics and some follow-up care because travel expenses are lower for U.S. residents living near the border. India is typically marketed for major savings on surgery and hospital-based treatment, while Turkey is often promoted for radiation therapy, surgical oncology and bundled care that includes translation and lodging support.
What is not publicly confirmed is a comprehensive country-by-country count of Americans traveling abroad specifically for cancer treatment. Neither the U.S. Centers for Disease Control and Prevention nor the U.S. State Department publishes a running total for oncology medical travel, and many hospitals do not break out U.S. cancer patients in public reporting.
Why patients go, and what it means for Americans weighing options
The main reason is cost. KFF, the American Cancer Society Cancer Action Network and multiple hospital pricing surveys have all documented how cancer care in the U.S. can involve high charges for infusions, scans, surgery and specialist visits, especially for people in high-deductible plans or those receiving care outside their insurer’s network.
There is also a timing factor in some cases. Medical tourism companies and several international hospitals say U.S. patients sometimes seek faster appointments, second opinions or bundled pricing abroad, though treatment quality, accreditation, follow-up care and medical record transfer can differ significantly by hospital and country.
For Americans considering Mexico, India or Turkey, the practical reality is that prices may be lower but treatment plans are not directly comparable line by line. The U.S. Centers for Disease Control and Prevention has said people seeking medical care abroad should confirm physician credentials, hospital accreditation, medication standards and plans for returning home, especially for complex care such as cancer treatment.
